To PARPI or Not to PARPI BRCA Mutated Ovarian Cancer Following First-line Chemotherapy, That is the Question?

Detalles Bibliográficos
Autores principales: Rose, Peter G, Chambers, Laura M, Kuznicki, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8681040/
https://www.ncbi.nlm.nih.gov/pubmed/34925958
_version_ 1784616883079610368
author Rose, Peter G
Chambers, Laura M
Kuznicki, Michelle
author_facet Rose, Peter G
Chambers, Laura M
Kuznicki, Michelle
author_sort Rose, Peter G
collection PubMed
description
format Online
Article
Text
id pubmed-8681040
institution National Center for Biotechnology Information
language English
publishDate 2021
record_format MEDLINE/PubMed
spelling pubmed-86810402021-12-17 To PARPI or Not to PARPI BRCA Mutated Ovarian Cancer Following First-line Chemotherapy, That is the Question? Rose, Peter G Chambers, Laura M Kuznicki, Michelle Gynecol Obstet (Sunnyvale) Article 2021 2021-08-03 /pmc/articles/PMC8681040/ /pubmed/34925958 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Article
Rose, Peter G
Chambers, Laura M
Kuznicki, Michelle
To PARPI or Not to PARPI BRCA Mutated Ovarian Cancer Following First-line Chemotherapy, That is the Question?
title To PARPI or Not to PARPI BRCA Mutated Ovarian Cancer Following First-line Chemotherapy, That is the Question?
title_full To PARPI or Not to PARPI BRCA Mutated Ovarian Cancer Following First-line Chemotherapy, That is the Question?
title_fullStr To PARPI or Not to PARPI BRCA Mutated Ovarian Cancer Following First-line Chemotherapy, That is the Question?
title_full_unstemmed To PARPI or Not to PARPI BRCA Mutated Ovarian Cancer Following First-line Chemotherapy, That is the Question?
title_short To PARPI or Not to PARPI BRCA Mutated Ovarian Cancer Following First-line Chemotherapy, That is the Question?
title_sort to parpi or not to parpi brca mutated ovarian cancer following first-line chemotherapy, that is the question?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8681040/
https://www.ncbi.nlm.nih.gov/pubmed/34925958
work_keys_str_mv AT rosepeterg toparpiornottoparpibrcamutatedovariancancerfollowingfirstlinechemotherapythatisthequestion
AT chamberslauram toparpiornottoparpibrcamutatedovariancancerfollowingfirstlinechemotherapythatisthequestion
AT kuznickimichelle toparpiornottoparpibrcamutatedovariancancerfollowingfirstlinechemotherapythatisthequestion

Ejemplares similares